Abstract: A combination RFID tag intended to be associated with a host product, for example by being secured to the outside of a package containing a perishable product, e.g. foodstuffs or vaccines, which RFID tag is provided with a visually readable environmental condition exposure indicator. The visual indicator can sense the exposure of the RFID tag to an environmental condition e.g. temperature, experienced by the host product providing a visual indication, e.g. a color change, readable externally of the RFID tag of the sensed environmental condition. The visual indicator can be chemically active, for example an acetylenic agent, and may be responsive to cumulative temperature excursions over time. The novel RFID tag 11 and tag inspection methods of the invention permit an efficacious harnessing of information about the condition exposure history of a specific inventory item including product identification and related data.

Abstract: A system for recovering a diacetylenic monomer shelf life monitoring compound of reduced particle size and narrow size distribution range which comprises quenching a solution of the monomer by mixing the solution in a lower temperature quenching fluid having a base temperature which is at least about 30° C. below the nominal temperature at which the monomer compound recrystallizes from solution, the mixing being effected in such a manner as to limit the resulting quenching mixture temperature to one which is not higher than a maximum of about 15° C. above the quenching fluid base temperature.

Abstract: Implants and associated delivery systems for promoting angiogenesis in ischemic tissue are provided. The implants may be delivered percutaneously, thoracically or surgically and are particularly well suited for implantation into the myocardium of the heart. The implants are configured to be flexible so that they compress and expand with corresponding movement of the surrounding tissue into which they are implanted. The flow of blood into the implant and pooling of the blood in and around the implant leads to thrombosis and fibrin growth, a healing process that leads to angiogenesis in the tissue surrounding the implant. Additionally, the implants may contain an angiogenic substance or a thrombus of blood, preloaded or injected after implantation to aid in initiating angiogenesis.